In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal disease. uri icon

authors

  • Lin, Brian Leei
  • Blair, Nathaniel T
  • Chong, Jayhong A
  • Hessler, David P
  • Bedja, Djahida
  • Zhu, Guangshuo
  • Muller, Grace K
  • Ranek, Mark J
  • Pantages, Lynn
  • McFarland, Mary
  • Netherton, Matthew R
  • Matera, Damian
  • Berry, Angela
  • Wong, Diane
  • Rast, Georg
  • Qian, Hu Sheng
  • Weldon, Steven M
  • Kuo, Jay J
  • Sauer, Achim
  • Sarko, Chris
  • Moran, Magdalene M
  • Kass, David A
  • Doerner, Julia F
  • Pullen, Steven S
  • Zheng, Nan
  • Del Camino, Donato
  • Mishra, Sumita
  • Bian, Hong
  • Zeveleva, Svetlana
  • Zhen, Xiaoguang

publication date

  • January 1, 2019